| I N TR ODU C TI ON
Mutations in the WDR45 gene are associated with an X-linked dominant form of neurodegeneration with brain iron accumulation (NBIA) (Haack et al., 2012) , referred to as beta-propeller protein-associated neurodegeneration (BPAN). The term NBIA, encompasses several single-gene disorders characterized by abnormal iron deposition in the basal ganglia (Gregory, Kurian, Haack, Hayflick, & Hogarth, 2017) .
To date, there are 10 genes established to be associated with NBIA, the three most common forms being caused by mutations in the PANK2 (OMIM 606157), C19orf12 (OMIM 614297), and PLA2G6 (OMIM 603604) genes, which encode mitochondria-associated proteins with no clear link to iron homeostasis. The X-linked WDR45 gene encodes a beta-propeller scaffold protein with a putative role in autophagy (Carvill et al., 2017) . Eight of the ten genetically defined types of NBIA are inherited in an autosomal recessive manner. Based on observed cases in the population, the prevalence of NBIA is estimated at 1-3/1,000,000 (Gregory & Hayflick, 2005) of which BPAN constitutes only one to two percent (Horvath 2013) .
Typical clinical features of BPAN include early-onset global developmental delay remaining essentially static until young adulthood when there is further neurological deterioration (Parkinsonism, dystonia, and dementia). Seizures and sleep disorders are also a relatively common feature. During the early years, the clinical picture is very nonspecific making diagnosis difficult (Gregory et al., 2017) .
A characteristic pattern observed on MRI in BPAN patients, though not to become apparent until the further neurological deterioration of young adulthood has occurred, is T1 hyperintensity surrounding a central linear region of signal hypointensity within the substantia nigra and cerebral peduncles. Cerebral and cerebellar atrophy are also observed.
The majority of mutations reported in WDR45 to-date are truncating mutations predicted to result in a loss of function. Mutations at the canonical splice site positions of several WDR45 exons have also previously been reported. Based on the positions of the mutations reported to date, there is no apparent mutational hotspot.
Here we describe how a genetic diagnosis of BPAN was reached in a 6-year-old child with a typical nonspecific phenotype, via the use of trio exome sequencing, in silico splicing analysis, and functional mRNA characterization demonstrating aberrant splicing as the result of a novel, relatively intronic variant in WDR45.
| C LI N I CA L R E POR T
The proband is the second child of healthy non-consanguineous, White
European parents with no significant family history of note. The pregnancy was uncomplicated with normal antenatal scans. She was born at term with a birth weight of 4,130 g and was in a good condition immediately after birth. There were no concerns immediately after birth but she was noted to have developmental delay in the first year of life.
At 1 year of age, she was only sitting unsupported, was not able to stand without support and just about being able to transfer objects.
She also developed seizures from 4 months of age, initially managed conservatively but requiring medical management soon thereafter. Further to this result the patient had MRI-brain scan performed at 4 years of age which showed mildly reduced T2 signal in bilateral globus pallidus on SWI and persistent white matter signal changes (Figure 2a,b) . Repeat MRI at 5 years of age (Figure 2c,d ) demonstrated mineralization within the dentate nuclei, globus pallidus, and substantia nigra, possibly in keeping with NBIA.
Her most recent clinical examination at 6 years of age demonstrated a very sociable young girl with good eye contact, developmental delay with moderate intellectual disability (needing special educational support). She was able to stand with support but had difficulty with her balance; she was crawling but unable to walk with support. She was using a wheelchair, remained non-verbal but had a very happy, friendly personality. She was wearing glasses for astigmatism and myopia but her hearing was reported to be normal. She continued to have multi-focal frequent myoclonic seizures needing treatment with multiple anti-epileptic medications including Lamotrigine, Topiramate, and more recently started on trial of sodium valproate in addition to the ketogenic diet to attain seizure-control. Her growth parameters included head circumference 52 cm (50th to 75th percentile), weight 24.2 kg (98th percentile), and height 111.5 cm (50th to 75th percentile).
| M A TER I A LS A N D M ETH OD S
This patient was recruited to the Deciphering Developmental Disorders (DDD) study, trio-based exome sequencing was performed on the affected individual and their parents, as previously described (Wright et al., 2015) . Each affected individual has also had a high-resolution analysis for copy number abnormalities using array-based comparative genomic hybridization (aCGH). Putative de novo mutations were identified from exome data using DeNovoGear software (Ramu et al., 2013) and were validated using targeted Sanger sequencing.
| In silico splicing analysis
The following in silico tools were utilized, accessed via Alamut Visual v2.9. 
| mRNA analysis
Epidermal fibroblasts were received as a confluent monolayer growth in a T25 flask. Cells were washed once using PBS then detached using a Trypsin-EDTA solution and centrifugation at 1,500 RPM for 5 min.
Cells were washed again once in PBS, and RNA extracted from half of the total volume using the RNeasy Mini Kit (Qiagen, Hilden, Germany) 
| In silico splicing analysis
In silico tools (see Section 3) indicated this variant may interfere with normal splicing at the exon 6 splice acceptor site. Although the NNSPLICE tool failed to offer a prediction, the other four tools all indicated activation of a cryptic exon 6 acceptor splice site at c.236-17
with abolition of the natural acceptor splice site at c.236. This variant was confirmed by Sanger sequencing on a genomic DNA sample from the proband, and Sanger sequencing on parental samples confirmed the de novo status of this variant. This variant was completely absent from population databases (gnomAD, 1000 genomes project). Given the variant's de novo status, the in silico prediction, the absence from population databases and the phenotype and MRI-imaging being consistent with the genotype, we undertook mRNA functional analysis on a blood sample and cultured fibroblasts in search of further evidence of an effect on splicing.
| mRNA analysis
After PCR across exons 3 to 8, gel electrophoresis revealed two major bands from both patient and wild-type control samples (see Figure 3) . product from the patient sample was also carried out and results Other investigators have demonstrated, from cells of patients with WDR45 truncating mutations, no evidence of truncated protein product, suggesting the mutant proteins are structurally unstable and undergoes degradation (Saitsu et al., 2013) .
| D I SCUSSION
For changes at canonical splice site positions (62 bp from the ends of exons), it is generally safe to assume a deleterious effect unless there is evidence to the contrary, but variants that lie deeper within an intron are much less likely to have a significant impact on splicing and so require further evidence to support a conclusion of pathogenicity, and for a clinical diagnosis in silico predictions cannot be relied upon alone. suggestive of skewed X-inactivation (Saitsu et al., 2013) suggesting this may form an inherent aspect of the disease mechanism. The number of female patients reported to date significantly outweighs that of males but the phenotype is similar between the sexes. Haack et al. (2012) have previously concluded that males with WDR45 mutations must be somatic mosaic, which was demonstrated in one affected male. It is thought therefore that males with germline WDR45 mutations may be nonviable. However, there are now several reports of surviving males with germline WDR45 variants (Redon et al., 2017; Takano et al., 2017) .
This case also serves as another example of the power of trio exome sequencing to find a relatively early diagnosis for a patient with very nonspecific clinical features, however it also demonstrates that for some variants further work is required in order to provide sufficient evidence for pathogenicity beyond de novo status.
